Uncategorized Archives - Page 6 of 248

FridayJun 28, 2024 9:45 am

Golden Triangle Ventures Inc. (GTVH) Announces Full Financial Support to Launch Freight Brokerage Division

Cargo Management Group acquisition includes a full-fledged logistics operation, brokerage business, licenses and all associated assets Acquisition helps move GTVH toward goal of becoming a highly profitable company with minimal to zero debt and a diverse asset portfolio Along with acquisition, company receives full financial support from T&K Zarro to fund key components of new venture In a strategic move that aligns with the company’s vision “to assemble a strong portfolio of successful businesses under one overarching umbrella” (https://cnw.fm/HWyV8), Golden Triangle Ventures (OTC: GTVH) (“GTV”) has announced a full-service freight brokerage business designed to significantly expand its logistics capabilities (https://cnw.fm/rMOmx).…

WednesdayJun 26, 2024 9:45 am

Software Effective Solutions Corp. (SFWJ) Partners with Leading Colombian Company as Global Cannabis Opportunities Increase

“A myriad of opportunities has emerged for (cannabis) investors, entrepreneurs and enthusiasts worldwide,” reports Newsweek MedCana’s agreement to begin exporting CBD buds to Switzerland appears to be particularly timely The company noted that this new collaboration marks a “significant milestone” in the company’s expansion into the European market Interest in cannabis is growing globally, and savvy companies operating in the cannabis space, such as Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), are working to strengthen their positions. Most recently, MedCana announced a new strategic partnership between one of its subsidiaries and a prominent Colombian company to begin export of its…

WednesdayJun 26, 2024 9:00 am

Golden Triangle Ventures Inc. (GTVH), Largest Note Holder Reach Agreement That Will Enhance Shareholder Value

GTVH enters pivotal agreement with largest note holder, T&K Zarro LLC CEO notes that agreement demonstrates “our commitment to strengthening our capital structure and delivering tangible value to our shareholders” The agreement is a “testament” to the company’s strategic foresight and dedication to fostering a robust and scalable business model Golden Triangle Ventures (OTC: GTVH) continues momentum as the company announces strategic steps in its commitment to solidifying its capital structure, expanding its business operations and enhancing shareholder value. Most recently, the company revealed a pivotal agreement with T&K Zarro LLC, GTVH’s largest note holder (https://cnw.fm/3mhs9). “This agreement marks a…

MondayJun 24, 2024 12:45 pm

CannaCon Midwest St. Paul To Move the Midwest Cannabis Industry Forward

CannaCon Midwest St. Paul invites like-minded entrepreneurs, investors, public officials, patients, and enthusiasts of the cannabis spectrum, to attend the CannaCon Midwest St. Paul conference August 16-17, 2024. This event is a one-stop solution for the cannabis community looking for resources, education, and collaboration opportunities, for all things cannabis. The CannaCon conference offers a phenomenal platform for enthusiasts, creatives, growers, and traders in and around the venue, to stay updated with the latest industry trends and develop the best networking connections. They will find the latest cultivation techniques, genetics, supplies, unique industry innovations, business, financial, and legal advice, marketing, branding…

MondayJun 24, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Second Round of Dosing for Human Pilot Study #2; Set to Complete Third Study Arm in Early July

Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration The study’s main objective is to evaluate Lexaria’s patented DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug, semaglutide, currently commercially available as Rybelsus(R) The commencement of the pilot study shows Lexaria’s commitment to its promise to focus on GLP-1 studies for 2024, along with its confidence in its…

MondayJun 24, 2024 9:45 am

Golden Triangle Ventures Inc. (GTVH) Completes Acquisition of Time-Tested, Proven Shipping and Logistics Operation

Through acquisition, management has agreed to use 10% of the profits from logistics business to buy back and retire GTVH stock “This transition marks a pivotal moment in our journey,” states exec Management is crafting a comprehensive business plan that substantially expands the company’s growth trajectory Golden Triangle Ventures (OTC: GTVH) continues to take strategic steps toward expanding and positioning the company for fundamental business income and financial independence. The latest in these steps is the completed acquisition of Cargo Management Group, a multifaceted logistics and trucking operation (https://cnw.fm/IjALN). According to the announcement, through this acquisition, management has agreed to use…

MondayJun 24, 2024 9:00 am

Software Effective Solutions Corp. (SFWJ) Notes Subsidiaries Making ‘Remarkable’ Advancements in Array of Sectors Around the World

Recent report projects global cannabis market to reach $444.34 billion by 2030 MedCana and its subsidiaries are focused on establishing stronghold in this expanding space MedCana is committed to advancing cannabis production and agricultural technology around the world, while also driving innovation and promoting sustainability The cannabis industry continues to grow, as it has consistently for the past several years. Recent projections value the global cannabis market at almost $445 billion by 2030 (https://cnw.fm/k4VDg). This is good news for Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), a leading entity in the cannabis and agricultural technology sectors. Recently, MedCana noted remarkable advancements…

MondayJun 17, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO; Set for First Tirzepatide Molecule Study

Lexaria, a global innovator in drug delivery platforms, recently announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study The study, a randomized, crossover investigation, will evaluate a dual-action glucagon-like peptide 1 (“GLP-1”) + glucose-dependent insulintropic peptide (“GIP”) It will measure absorption, tolerability, pharmacokinetics, and blood sugar levels Lexaria is counting on its patented DehydraTECH technology for significant growth in the 2024 calendar year, and the study reflects this commitment Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the hiring of a Contract Research Organization (“CRO”) for its third human…

FridayJun 14, 2024 9:45 am

Astrotech Corp. (NASDAQ: ASTC) Expands Role of Mass Spectrometry in Industrial Processes

In the chemical manufacturing industry, innovative uses of mass spectrometry are a game-changer by ensuring quality control, increased yields, and increased profits Astrotech subsidiary, Pro-Control Inc., has positioned its product line between the need for the chemical manufacturers to offset lower prices with efficiency gains that could offset potential losses The Pro-Control Maximum Value Processing(TM) can perform in-situ process tests every 5 minutes greatly increasing efficiency across a wide range of chemical manufacturing processes Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme…

FridayJun 14, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases

INM is advancing INM-089 targeting age-related macular degeneration and INM-901 targeting Alzheimer’s disease The company recently posted positive results for INM-089 demonstrating significant functional and pathological improvements in an AMD disease model Recent preclinical data for INM-901 displayed positive pharmacological effects for treating Alzheimer's disease INM posted a business update for Q3-2024 reporting a closing cash position of US$7.9 million and revenue growth for subsidiary BayMedica, a supplier of rare cannabinoids as ingredients InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized